Tuesday, 09 Jul 2019 6:00 PM
JLM-BIOCITY Bio Startup Pitch Evening
Tuesday, July 9th, 2019
The event will take place in the new building C-203
JLM-BioCity is organizing for an evening event for both Biomed and Pharma Startups pitching to a panel of investors:
* Ilan Goldstein, Principal, Elan Global Group & Merchavia Group
* Jonathan Goldstein, Director, Corporate R&D &Venture, Boston Scientific
* Noga Yerushalmi, Head of M-Ventures
* Yuval Cabilly, General Partner, Israel Biotech Fund
Companies pitching will be CONCENTER BIOPHARMA,
OMNYSENSE, OMNIX MEDICAL, NEUROGENESIS, VIRUCURE, VAXIL
The purpose of these events is to give a platform for promising life science/Biomed start-ups to present themselves to a forum of investors. In addition, it will help other bio-entrepreneurs to learn how to better pitch their start-ups and to acquaint themselves with investors.
JLM-BioCity is delighted to announce this event is sponsored by Azrieli College of Engineering and AtoBe, Azrieli College’s Startup Entrepreneurship Center as well as the OJC
Presentations will be in English.
RSVP to reserve your place.
NOTE: We ask you for a 20 NIS donation at the entrance to the event. The JLM-BioCity Team are all volunteers, but we have expenses to cover. Thank you for your donation in advance.
ENTRANCE TO THE AZRIELI COLLEGE OF ENGINEERING WILL ONLY BE FOR PEOPLE WHO HAVE RVSP’ED ON THIS SITE AND SENT THEIR NAME IN HEBREW AND CAR LICENCE to the enclosed form:
(If you answer in English, we will translate for you).
18:00-18:30 Registration & Networking
18:30-18:40 MODERATOR – David Waiman, OurCrowd & JLM-BioCity
Deborah Shaked – Hd Pharma Engineering – Azrieli College
Fleur Hassan Nahum – Dep. Mayor, City of Jerusalem
Shay Fleishon – Bio-Jerusalem
Lili Pergamenkov -Aspire & AtoBe, Azrieli College
CONCENTER BIOPHARMA – Dror Chevion
OMNYSENSE – Ian Solomon
OMNIX MEDICAL -Niv Bachnoff
NEUROGENESIS – Nir Netzer
VIRUCURE – Shay Tayeb
VAXIL – Mordechai Applebaum
9:35-19:40 Sum up by Panel
ILAN GOLDSTEIN, Director of Merchavia and BIO-Tech Investment (Public MRHL: Israel), has been instrumental in transforming the Company from a real estate investment focus to a Bio-Tech investment focus, including building strategic investments relations with leading players from the health care industry. Also serves as the CEO of Slope Realty Co., which manages and develops real estate properties across the US, Europe and Israel. In addition, he is also the CEO of Elan Global Group, a Hi-Tech Investments group that builds and manages a high-tech investment portfolio. Ilan earned his Law degree from Fordham University.
JONATHAN GOLDSTEIN focuses on strategic VC investments in Europe and Israel. He has been working for Boston Scientific Corporation (BSC) since 2012, interfacing with Israeli technology and projects, and generating collaborations across the spectrum of BSC’s R&D, Venture and Business Development functions. Also manages the Corporate Research Division’s Worldwide Scouting Team, supporting Divisional & Corporate teams in identifying relevant next-generation technologies and companies for the company’s pipeline. Holds a BSc. in Chemistry & Biochemistry from Imperial College, London, & an MBA from the University of London.
NOGA YERUSHALMI Ph.D. is Hd of the Bioincubator in Israel and Hd of PMatX, representing M Ventures in Israel. Graduate of Tel-Aviv University and with a postdoctoral fellowship at NIH, USA. Over 20 years of experience in the Israeli Biotech industry. Before joining M Ventures, Noga served as Hd of HTS at Zetiq, Hd Therapeutics at Rosetta Genomics, and Scouting and BD at FutuRx.
YUVAL CABILLY Ph.D. is co-Founder &General Partner of Israel Biotech Fund, with vast experience in identifying, funding and engaging in business development activities of Israeli biotech companies. Received his Ph.D. in molecular cell biology from Tel Aviv University.